Prot #RAIN-701: A Phase 2 Study to Evaluate the Clinical Activity of Tarloxotinib in Patients with Non-Small Cell Lung Cancer that Harbors Either an EGFR Exon 20 Insertion or a HER2-Activating Mutation and Other Advanced Solid Tumors with NRG1/ERBB Family

Project: Research project

Project Details

Effective start/end date4/29/204/29/23


  • NCGS, Inc. (Prot #RAIN-701)
  • Rain Therapeutics Inc. (Prot #RAIN-701)